超越了正规的 PROTAC:生物向蛋白质降解 (bioTPD)
Huifang Wang1, Runhua Zhou2, Fushan Xu3
1Shenzhen Institute of Respiratory Disease, Shenzhen Clinical Research Centre for Respirology, The Second Clinical Medical College, The First Affiliated Hospital, Shenzhen People's Hospital, Jinan University, Southern University of Science and Technology, Shenzhen, 518020, Guangdong, P. R. China.
Biomaterials research
|July 21, 2023
概括
生物向蛋白降解 (bioTPD) 提供了向以前无法药物处理的蛋白质的新方法. 本综述涵盖了生物TPD技术的进步,其应用以及临床开发策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 向性蛋白质降解 (TPD) 利用细胞机械来降解与疾病相关的蛋白质.
- 针对蛋白质溶解的嵌合体 (PROTACs) 已经将TPD从学术界扩展到临床领域.
- 小分子TPD是一个突出的领域,但生物TPD (生物TPD) 正在迅速发展.
研究的目的:
- 提供关于生物TPD技术近期进展的概述.
- 总结生物TPD的组成特征和潜在应用.
- 讨论改善用于临床开发的生物TPD交付的缺点和战略.
主要方法:
- 关于生物TPD的最新科学文献的审查.
- 分析不同的生物TPD模式 (,融合蛋白,抗体,基于核酸的).
- 讨论交付策略和临床挑战.
主要成果:
- 生物TPD技术已经显示出显著的进步和独特的活动超出了小分子TPD.
- 不同的生物TPD方法显示出各种潜在的应用.
- 传递疗效仍然是临床翻译的一个关键挑战.
结论:
- 生物TPD代表了治疗策略的前途前沿,用于以前无法治疗的目标.
- 对传递方法的进一步研究对于生物TPD的临床成功至关重要.
- 生物TPD技术提供了具有重大潜力的新疗法途径.
相关概念视频
Regulated Protein Degradation
7.4K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.4K
The Proteasome
8.8K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.8K
Proteins: From Genes to Degradation
12.3K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
12.3K
The Proteasome Structure
807
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
807
Regulation of Expression at Multiple Steps
944
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
944
Export of Misfolded Proteins out of the ER
3.7K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.7K


